Comparative proteomic profiling of human osteoblast‐derived extracellular matrices identifies proteins involved in mesenchymal stromal cell osteogenic differentiation and mineralization

• Published in: Journal of cellular physiology Vol. 233; no. 1; pp. 387 - 395
• Main Authors: Baroncelli, Marta, van der Eerden, Bram C., Kan, Yik‐Yang, Alves, Rodrigo D., Demmers, Jeroen A., van de Peppel, Jeroen, van Leeuwen, Johannes P.
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.01.2018
• Subjects: Activin; Activins - pharmacology; Activin‐A; Architecture; Biocompatibility; Biomedical materials; Bone growth; bone regeneration; Calcification, Physiologic - drug effects; Cell Differentiation - drug effects; Differentiation (biology); Electrophoresis, Polyacrylamide Gel; Extracellular matrix; Extracellular Matrix Proteins - metabolism; Humans; Mass Spectrometry; Membrane proteins; Mesenchymal stem cells; mesenchymal stromal cells; Mesenchymal Stromal Cells - drug effects; Mesenchymal Stromal Cells - metabolism; Mesenchyme; Mineralization; Mitochondria; Osteoblasts - drug effects; Osteoblasts - metabolism; Osteogenesis - drug effects; Phenotype; Proteins; Proteomics - methods; Regeneration; Regeneration (physiology); Regulatory proteins; Ribosomal proteins; Ribosomal Proteins - metabolism; Skin & tissue grafts; Stem cells; Therapeutic applications; Time Factors; bone regeneration; Activin-A; extracellular matrix; mesenchymal stromal cells
• ISSN: 0021-9541; 1097-4652
• DOI: 10.1002/jcp.25898

The extracellular matrix (ECM) is a dynamic component of tissue architecture that physically supports cells and actively influences their behavior. In the context of bone regeneration, cell‐secreted ECMs have become of interest as they reproduce tissue‐architecture and modulate the promising properties of mesenchymal stem cells (MSCs). We have previously created an in vitro model of human osteoblast‐derived devitalized ECM that was osteopromotive for MSCs. The aim of this study was to identify ECM regulatory proteins able to modulate MSC differentiation to broaden the spectrum of MSC clinical applications. To this end, we created two additional models of devitalized ECMs with different mineralization phenotypes. Our results showed that the ECM derived from osteoblast‐differentiated MSCs had increased osteogenic potential compared to ECM derived from undifferentiated MSCs and non‐ECM cultures. Proteomic analysis revealed that structural ECM proteins and ribosomal proteins were upregulated in the ECM from undifferentiated MSCs. A similar response profile was obtained by treating osteoblast‐differentiating MSCs with Activin‐A. Extracellular proteins were upregulated in Activin‐A ECM, whereas mitochondrial and membrane proteins were downregulated. In summary, this study illustrates that the composition of different MSC‐secreted ECMs is important to regulate the osteogenic differentiation of MSCs. These models of devitalized ECMs could be used to modulate MSC properties to regulate bone quality. In vitro cell‐derived extracellular matrices (ECM) mimic the ECM role in tissue architecture and in actively modulating cell behavior, and they have been proposed for tissue engineering applications. We created three models of human osteoblast‐derived ECM with extremely different mineralization phenotypes, to identify regulatory proteins to modulate mesenchymal stromal cell (MSC) differentiation. Comparative proteomic profiles of these ECMs reveal that the protein composition is important to regulate MSC behavior, and could be used to modulate MSC properties and bone quality for bone tissue engineering applications.